LDN Social Media
Get connected with us on social networks
LDN Community
Join our community here.
This video by Dr. Sarah Zielsdorf, MD, MS explores innovative immunotherapeutic strategies for managing endometriosis. It delves into methods for reducing hypoxia, modulating immune cell activity, and targeting autoantibodies. Key treatments discussed include low-dose naltrexone (LDN), TNF-antagonists, and immunomodulatory vaccines like BCG, offering a comprehensive overview of current research and potential future therapies.
Dr. Sarah Zielsdorf, MD, MS:
This paper does an excellent job at discussing very specific ways to target endometriosis from an immune system perspective. So these are imunotherrapeutic approaches. So, starting at the top at about the 11:00 position, talking about things like how to reduce the hypoxia or lack of oxygen and how do we reduce auto antibodies and I would argue this is where we want to talk about lowd dose nrexone going clockwise here immunotherapy by blocking natural killer cells and other immunom modulatory vaccines. These are all experimental and here we go. Specifically lowd dose nrexone opioid receptor antagonism LDN modulation of bone marrow dendritic cells macrofasages and inhibition of tolic receptor 4. LDN will help to repress proliferation of CD4, CD8 positive T- cells and belymphosytes. We're talking about ones that would be disruptive. And in patients with lesser pelvic pain syndrome, we can stabilize or reduce their symptoms. In addition, these are other conditions over here going around that are possible treatments.
We have a new private LDN Community, not associated with any social media platform. Please visit www.ldnrtcommunity.org to join.
Our webinars and training courses can be purchased from https://www.ldnrtevents.com/collections/webinars-and-training-courses.
We have a list of LDN Q&As on our website which you can peruse by visiting https://ldnresearchtrust.org/questions-and-answers.
Visit our website at https://www.ldnresearchtrust.org which is packed with information on Low Dose Naltrexone (LDN) for Autoimmune Conditions, Cancers, Chronic Pain, Women's Health and more.